四联化疗治疗肝转移引起的黄疸
The treatment of jaundice due to liver metastases by quadruple chemotherapy.
作者信息
Hughes J, Stoker T A
出版信息
Postgrad Med J. 1973 Apr;49(570):265-7. doi: 10.1136/pgmj.49.570.265.
Abstract
This is a report of seven patients with jaundice due to extensive hepatic secondary deposits, who were treated with combination chemotherapy. In six cases the jaundice was relieved and biochemical and liver function tests improved. Three patients survived for 1 year or longer.
摘要
这是一份关于7例因广泛肝脏继发性转移瘤导致黄疸并接受联合化疗患者的报告。6例患者黄疸缓解，生化及肝功能检查改善。3例患者存活1年或更长时间。
相似文献
1
The treatment of jaundice due to liver metastases by quadruple chemotherapy.四联化疗治疗肝转移引起的黄疸
Postgrad Med J. 1973 Apr;49(570):265-7. doi: 10.1136/pgmj.49.570.265.
2
Results of 27 cases with hepatic metastases treated by combination chemotherapy.
Br J Cancer. 1972 Dec;26(6):466-72. doi: 10.1038/bjc.1972.64.
3
Treatment of hepatic metastases from breast cancer.
Clin Oncol. 1978 Jun;4(2):167-71.
4
Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.绝经后女性转移性乳腺癌的化疗：环磷酰胺与环磷酰胺、长春新碱、甲氨蝶呤、5-氟尿嘧啶和泼尼松五药联合方案的对照试验
Prog Clin Biol Res. 1977;12:459-66.
5
Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma.原发性肝细胞癌治疗中四联化疗与放射治疗的比较
Cancer. 1977 Aug;40(2):609-14. doi: 10.1002/1097-0142(197708)40:2<609::aid-cncr2820400203>3.0.co;2-l.
6
[Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)].
Med Klin. 1976 Oct 1;71(40):1676-83.
7
Combination chemotherapy for advanced mammary carcinoma: a twelve-year experience.
Mt Sinai J Med. 1972 Sep-Oct;39(5):435-46.
8
Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
Eur J Cancer (1965). 1980;Suppl 1:141-6.
9
[Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].
Internist (Berl). 1973 Dec;14(12):643-52.
10
[Place of chemotherapy in the treatment of primary bronchial cancers].
Bronches. 1972 May-Jun;22(3):176-89.
本文引用的文献
1
Chemotherapy for liver cancer by protracted ambulatory infusion.
JAMA. 1965 Nov 1;194(5):481-6.
2
Factors influencing survival in patients with untreated hepatic metastases.影响未经治疗的肝转移患者生存的因素。
Surg Gynecol Obstet. 1968 Jul;127(1):1-11.
3
Prognostic factors affecting adrenalectomy in patients with metastatic cancer of the breast.影响乳腺癌转移患者肾上腺切除术的预后因素。
Cancer. 1971 May;27(5):1106-11. doi: 10.1002/1097-0142(197105)27:5<1106::aid-cncr2820270516>3.0.co;2-#.
4
The influence of treatment on the survival of patients with hepatic metastases diagnosed by liver scanning.治疗对经肝脏扫描诊断为肝转移患者生存率的影响。
Am J Roentgenol Radium Ther Nucl Med. 1970 Aug;109(4):749-54. doi: 10.2214/ajr.109.4.749.
5
Survival of patients treated with systemic fluorouracil for hepatic metastases.接受全身性氟尿嘧啶治疗肝转移的患者的生存率。
Surg Gynecol Obstet. 1970 May;130(5):773-7.
6
Seventy-five cases of solid tumours treated by a modified quadruple chemotherapy regime.75例实体瘤采用改良四联化疗方案治疗。
Br J Cancer. 1971 Sep;25(3):462-78. doi: 10.1038/bjc.1971.59.
7
Intrahepatic arterial infusion with 5-fluorouracil.
Cancer. 1971 Nov;28(5):1147-51. doi: 10.1002/1097-0142(1971)28:5<1147::aid-cncr2820280510>3.0.co;2-l.
8
Combination chemotherapy using cyclophosphamide, vincristine, methotrexate and 5-fluorouracil in solid tumors.
Cancer. 1969 Mar;23(3):589-96. doi: 10.1002/1097-0142(196903)23:3<589::aid-cncr2820230310>3.0.co;2-a.
Zotero 插件